The off period is mainly there to address copper-accumulation concern from the GHK-Cu component, which makes up 62.5% of the blend
What this tail actually does in practice Initial binding to the cell surface via electrostatic interactions Internalization through a mixture of: direct translocation (rare but possible with strong polyArg motifs) endocytosis (the dominant route for most CPPs) Partial endosomal escape PolyArg motifs can destabilize endosomal membranes, but escape efficiency varies widely
For active adults already on IV nutrient therapy or working through a GLP-1 protocol, BPC-157s anti-inflammatory and recovery properties can be complementary
While both compounds work through different mechanisms that theoretically could complement each other, the safety, efficacy, and optimal dosing of this combination remain completely unknown
Optimizing when and how you take BPC-157 can influence its effectiveness
Just trying to understand what Congress is doing is not a simple thing